| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.854 | 55.469 | 50.746 | 51.078 | 62.858 | 65.379 | 93.465 | 107.004 | 66.106 | 29.522 |
| Total Income - EUR | 31.854 | 56.187 | 50.965 | 51.116 | 62.969 | 72.184 | 93.528 | 107.004 | 66.125 | 29.663 |
| Total Expenses - EUR | 30.493 | 30.254 | 34.640 | 39.047 | 43.335 | 56.166 | 65.199 | 59.206 | 82.286 | 42.809 |
| Gross Profit/Loss - EUR | 1.360 | 25.933 | 16.325 | 12.069 | 19.634 | 16.017 | 28.329 | 47.798 | -16.161 | -13.146 |
| Net Profit/Loss - EUR | 400 | 25.370 | 14.839 | 11.558 | 19.004 | 15.412 | 27.501 | 46.749 | -16.809 | -14.036 |
| Employees | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 4 | 3 | 2 |
Check the financial reports for the company - Biodent 94 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 59.770 | 56.495 | 53.403 | 50.374 | 50.183 | 48.771 | 51.228 | 50.038 | 46.055 | 42.753 |
| Current Assets | 11.582 | 6.176 | 37.032 | 12.376 | 13.883 | 21.488 | 36.891 | 71.986 | 13.187 | 3.810 |
| Inventories | 3.319 | 0 | 282 | 580 | 604 | 0 | 0 | 599 | 0 | 0 |
| Receivables | 5.209 | 5.114 | 5.724 | 5.013 | 4.851 | 2.086 | 4.305 | 54.388 | 2.085 | 2.010 |
| Cash | 3.054 | 1.062 | 31.025 | 6.783 | 8.427 | 19.401 | 32.587 | 16.999 | 11.102 | 1.800 |
| Shareholders Funds | 20.733 | 9.990 | 24.661 | 35.766 | 50.752 | 53.231 | 79.552 | 77.299 | 13.648 | -465 |
| Social Capital | 45 | 45 | 44 | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 50.697 | 52.705 | 65.999 | 26.985 | 13.315 | 17.027 | 8.567 | 44.725 | 45.595 | 47.027 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Biodent 94 S.r.l.